Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Bristol-Myers Squibb
>
CV Division and Celgene Acquisition
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 6238647"]The co-promotion agreements are in place for this scenario. Pfizer will take Eliquis and Janssen will take the factor XIa. There is a reason the Janssen deal was put in place before phase II trials completed. CV sell off will fund part of the massive price of the Celgene deal. </p><p><br /></p><p>Bottom line is that Pfizer already has an eliquis salesforce and Janssen will use their current team to transition from Xarelto to an OAC that doesn’t suck when they launch XIa. The odd ones out will be the current Eliquis salesforce. </p><p><br /></p><p>It’s not a coincidence that there has been zero CV pipeline for years and none of the promised acquisitions have materialized. CV is going the way of the diabetes divestiture a few years back.[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 6238647"]The co-promotion agreements are in place for this scenario. Pfizer will take Eliquis and Janssen will take the factor XIa. There is a reason the Janssen deal was put in place before phase II trials completed. CV sell off will fund part of the massive price of the Celgene deal. Bottom line is that Pfizer already has an eliquis salesforce and Janssen will use their current team to transition from Xarelto to an OAC that doesn’t suck when they launch XIa. The odd ones out will be the current Eliquis salesforce. It’s not a coincidence that there has been zero CV pipeline for years and none of the promised acquisitions have materialized. CV is going the way of the diabetes divestiture a few years back.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Bristol-Myers Squibb
>
CV Division and Celgene Acquisition
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Bristol-Myers Squibb
>
CV Division and Celgene Acquisition
>